207 related articles for article (PubMed ID: 27373283)
1. [Clinical analysis of cutaneous manifestations and related factors in patients with ulcerative colitis].
Tian Y; Li JX; Wang HH; Li RY; Liu XG
Zhonghua Nei Ke Za Zhi; 2016 Jul; 55(7):505-9. PubMed ID: 27373283
[TBL] [Abstract][Full Text] [Related]
2. Predictive factors for erythema nodosum and pyoderma gangrenosum in inflammatory bowel disease.
Ampuero J; Rojas-Feria M; Castro-Fernández M; Cano C; Romero-Gómez M
J Gastroenterol Hepatol; 2014 Feb; 29(2):291-5. PubMed ID: 23927379
[TBL] [Abstract][Full Text] [Related]
3. Mucocutaneous manifestations of inflammatory bowel disease in Turkey.
Topaloğlu Demir F; Kocatürk E; Yorulmaz E; Adalı G; Kavala M
J Cutan Med Surg; 2014 Nov; 18(6):397-404. PubMed ID: 25348761
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous manifestations in inflammatory bowel disease.
Tromm A; May D; Almus E; Voigt E; Greving I; Schwegler U; Griga T
Z Gastroenterol; 2001 Feb; 39(2):137-44. PubMed ID: 11253504
[TBL] [Abstract][Full Text] [Related]
5. Dermatologic manifestations in inflammatory bowel disease in Tunisia.
Mebazaa A; Aounallah A; Naija N; Cheikh Rouhou R; Kallel L; El Euch D; Boubaker J; Mokni M; Filali A; Ben Osman A
Tunis Med; 2012 Mar; 90(3):252-7. PubMed ID: 22481199
[TBL] [Abstract][Full Text] [Related]
6. Mucocutaneous manifestations of inflammatory bowel disease in central China -a single-centre study.
Kou CX; Zhang YY; Li GW; Li J; Kong QT; Chen J; Liu F; Zhang M; Wang FY; Jiang Y; Hao LY; Ren JA; Sang H
J Eur Acad Dermatol Venereol; 2018 Jun; 32(6):e211-e212. PubMed ID: 29194792
[No Abstract] [Full Text] [Related]
7. Dermatologic manifestations in pediatric patients with inflammatory bowel disease.
Afarideh M; Bartoletta K; Tollefson MM
Pediatr Dermatol; 2024; 41(2):234-242. PubMed ID: 38326222
[TBL] [Abstract][Full Text] [Related]
8. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
9. [Cutaneous manifestations with ulcerative colitis].
Arai S; Katsuoka K
Nihon Rinsho; 1999 Nov; 57(11):2571-4. PubMed ID: 10572433
[TBL] [Abstract][Full Text] [Related]
10. Occurrence of skin manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study.
Roth N; Biedermann L; Fournier N; Butter M; Vavricka SR; Navarini AA; Rogler G; Scharl M;
PLoS One; 2019; 14(1):e0210436. PubMed ID: 30682031
[TBL] [Abstract][Full Text] [Related]
11. Concomitant occurrence of pyoderma gangrenosum and erythema nodosum in inflammatory bowel disease.
Goldberg I; Finkel O; Gat A; Sprecher E; de Morentin HM
Isr Med Assoc J; 2014 Mar; 16(3):168-70. PubMed ID: 24761705
[TBL] [Abstract][Full Text] [Related]
12. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort.
Vavricka SR; Brun L; Ballabeni P; Pittet V; Prinz Vavricka BM; Zeitz J; Rogler G; Schoepfer AM
Am J Gastroenterol; 2011 Jan; 106(1):110-9. PubMed ID: 20808297
[TBL] [Abstract][Full Text] [Related]
13. Significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel diseases: a cohort study of 2402 patients.
Farhi D; Cosnes J; Zizi N; Chosidow O; Seksik P; Beaugerie L; Aractingi S; Khosrotehrani K
Medicine (Baltimore); 2008 Sep; 87(5):281-293. PubMed ID: 18794711
[TBL] [Abstract][Full Text] [Related]
14. Mucocutaneous manifestations in inflammatory bowel disease.
Yüksel I; Başar O; Ataseven H; Ertuğrul I; Arhan M; Ibiş M; Dağli U; Demirel BT; Ulker A; Seçilmiş S; Saşmaz N
Inflamm Bowel Dis; 2009 Apr; 15(4):546-50. PubMed ID: 19023896
[TBL] [Abstract][Full Text] [Related]
15. TRAF3IP2 gene is associated with cutaneous extraintestinal manifestations in inflammatory bowel disease.
Ciccacci C; Biancone L; Di Fusco D; Ranieri M; Condino G; Giardina E; Onali S; Lepre T; Pallone F; Novelli G; Borgiani P
J Crohns Colitis; 2013 Feb; 7(1):44-52. PubMed ID: 22445837
[TBL] [Abstract][Full Text] [Related]
16. Clinical manifestations of pyoderma gangrenosum associated with inflammatory bowel disease.
Menachem Y; Gotsman I
Isr Med Assoc J; 2004 Feb; 6(2):88-90. PubMed ID: 14986464
[TBL] [Abstract][Full Text] [Related]
17. Characterization and prevalence of extraintestinal manifestations in a cohort of patients with inflammatory intestinal disease in Medellin, Colombia.
Juliao-Baños F; Arrubla M; Osorio L; Camargo J; Londoño J; Cáceres C; Carvajal J; Mosquera-Klinger G; Donado J
Gastroenterol Hepatol; 2021; 44(6):398-404. PubMed ID: 33172691
[TBL] [Abstract][Full Text] [Related]
18. The Risk of Later Diagnosis of Inflammatory Bowel Disease in Patients With Dermatological Disorders Associated With Inflammatory Bowel Disease.
King D; Chandan JS; Thomas T; Nirantharakumar K; Reulen RC; Adderley NJ; Trudgill N
Inflamm Bowel Dis; 2021 Oct; 27(11):1731-1739. PubMed ID: 34669933
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory Cutaneous Lesions in Inflammatory Bowel Disease Treated With Vedolizumab or Ustekinumab: An ECCO CONFER Multicentre Case Series.
Phillips FM; Verstockt B; Sebastian S; Ribaldone D; Vavricka S; Katsanos K; Slattery E; de Suray N; Flores C; Fries W; Vincenzi F; Capoferro E; Bachmann O; Kopylov U
J Crohns Colitis; 2020 Oct; 14(10):1488-1493. PubMed ID: 32318735
[TBL] [Abstract][Full Text] [Related]
20. [Immune-mediated inflammatory diseases in patients with inflammatory bowel disease. Baseline data from the Aquiles study].
Marín-Jiménez I; García Sánchez V; Gisbert JP; Lázaro Pérez Calle J; Luján M; Gordillo Ábalos J; Tabernero S; Juliá B; Romero C; Cea-Calvo L; García-Vicuña R; Vanaclocha F
Gastroenterol Hepatol; 2014 Nov; 37(9):495-502. PubMed ID: 24717523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]